I'm preparing for the IBD specialty certification and the amount of reading material out there is genuinely overwhelming. The gastroenterology literature on Crohn's and UC management keeps getting updated, and I'm trying to figure out which resources are actually worth my time versus which ones are just padding.
I've been using the ACG and ECCO guidelines as my primary references, and supplementing with recent NEJM and Gastroenterology journal articles. But I'm not sure how closely the exam mirrors current clinical guidelines versus more foundational pathophysiology content.
The biologics section is where I feel least confident — there are so many agents now with overlapping mechanisms and the positioning decisions in moderate-to-severe disease keep shifting. Is the exam heavy on that, or does it still weight the older 5-ASA and immunomodulator content pretty evenly?
I'm sitting for it in September so I have about 3.5 months. Trying to build a realistic weekly study schedule rather than cramming at the end.
I passed last year and the biologics section was absolutely the hardest part. Vedolizumab vs anti-TNF decision-making in specific patient profiles came up more than once. ECCO guidelines complemented ACG well for the Crohn's fistulizing disease content specifically.
ACG guidelines are the right anchor — the exam committee pulls heavily from those. For biologics, I'd focus on mechanism of action, positioning (first-line vs second-line vs rescue), and the key safety monitoring differences. That cluster of knowledge covers a disproportionate share of questions.
3.5 months is plenty if you're structured about it. I'd do 6-week domain blocks — pathophysiology and diagnosis first, then medical management, then surgery and complications. Saving biologics for weeks 10-12 when you have the foundational context makes it stick better.